- 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy
Cardillo, G., Mokhles, S., Williams, N., Macbeth, F., Russell, C., Treasure, T. (2015). Comment on: 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy. BRITISH JOURNAL OF CANCER, 113 (11), 1636. doi:10.1038/bjc.2015.331
issuu Widget Placeholder33644033/62959599 - In Regard to Hepel and Wazer
Vaidya, J. S., Bulsara, M., Wenz, F., Joseph, D., Saunders, C., Massarut, S., Flyger, H., Eiermann, W., Alvarado, M., Esserman, L., Falzon, M., Brew-Graves, C., Potyka, I., Tobias, J., Baum, M. (2015). In Regard to Hepel and Wazer. International Journal of Radiation Oncology Biology Physics, 92(5), 953-954. doi:10.1016/j.ijrobp.2015.05.038
issuu Widget Placeholder33644033/62959674 - Pride, Prejudice, or Science: Attitudes Towards the Results of the TARGIT-A Trial of Targeted Intraoperative Radiation Therapy for Breast Cancer
Vaidya, J. S., Bulsara, M., Wenz, F., Joseph, D., Saunders, C., Massarut, S., Flyger, H., Eiermann, W., Alvarado, M., Esserman, L., Falzon, M., Brew-Graves, C., Potyka, I., Tobias, J., Baum, M. (2015). Pride, Prejudice, or Science: Attitudes Towards the Results of the TARGIT-A Trial of Targeted Intraoperative Radiation Therapy for Breast Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 92(3), 491-497. doi:10.1016/j.ijrobp.2015.03.022
issuu Widget Placeholder33644033/62959771